STARFISH Clinical Trial

The STARFISH trial aims to find out which of the different available steroid treatments works best in improving the hearing of patients suffering from Idiopathic Sudden Sensorineural Hearing Loss.

This study is funded by the NIHR Health Technology Assessment (HTA) programme (NIHR131528). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.